vial

(redirected from multiple-dose vial)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for vial

a small bottle that contains a drug (especially a sealed sterile container for injection by needle)

Related Words

References in periodicals archive ?
A recent online survey of 5,446 HCWs reveals noncompliance with basic infection control practices associated with the use of syringes, needles, multiple-dose vials, single-use vials and flush solutions.9 The study showed that:
Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit.
(8,9) In the current study 165 of 205 vials (80.49%) were SDVs that were used as multiple-dose vials. This finding is more than reported percentage of 50% in the literature.
Its products--which include anti-infection drugs, chemotherapy drugs, and critical care treatments used to stabilize cardiac conditions like blood clotting and arrhythmia--consist of more than 20 ready-to-use pre-filled syringes, single and multiple-dose vials, and pre-mix bags.
More than a million multiple-dose vials of heparin are sold each month in the United States, and about half of those are manufactured and distributed by Baxter.
* If multiple-dose vials are used, restrict them to a centralized medication area or for single patient use.
It was used in multiple-dose vials of vaccines to prevent bacterial contamination of the vials, and thus bacterial infection of the immunized child.
Last month, the FDA announced Baxter had stopped making multiple-dose vials because of an increase in reports of severe allergic reactions in patients receiving bolus injections of the company's heparin.
11, the FDA announced that Baxter had stopped making multiple-dose vials of heparin because of an increase in reports of severe allergic reactions in patients receiving bolus injections of the company's heparin.
prompted the company in February to temporarily stop manufacturing multiple-dose vials of heparin, the Food and Drug Administration announced.
Pharmaceutical company Mylan Inc (NasdaqGS:MYL) reported on Thursday the receipt of final approval for its Abbreviated New Drug Application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100 mg/mL, packaged in 200 mg/2 mL multiple-dose vials.
The medicine is packed in 200 mg/2 mL multiple-dose vials. It is to be utilised for the treatment of thiamine deficiency.
Full browser ?